×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: RNA Splicing in Neurodegeneration
mechanism
1,405 words
KG: RNA Splicing in Neurodegeneration
2026-03-21
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
RNA Splicing in Neurodegeneration
⚙
Mechanism Info
Name
RNA Splicing in Neurodegeneration
Summary
Page for RNA Splicing in Neurodegeneration
Knowledge Graph
Related Hypotheses (30)
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Multi-Modal Stress Response Harmonization
Score: 0.60
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
Microbial Inflammasome Priming Prevention
Score: 0.58
PARP1 Inhibition Therapy
Score: 0.58
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56
Smartphone-Detected Motor Variability Correction
Score: 0.56
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56
Adenosine-Astrocyte Metabolic Reset
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
Circadian Clock-Autophagy Synchronization
Score: 0.55
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Retinal Vascular Microcirculation Rescue
Score: 0.54
Show 25 more
Related Analyses (30)
What determines the specificity of RNA-protein interactions
neurodegeneration · failed
How do dilncRNAs specifically drive molecular crowding and p
neurodegeneration · completed
What determines the specificity of DDR protein recruitment t
neurodegeneration · completed
Do chronic stress granule inhibition strategies impair norma
neurodegeneration · failed
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · failed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Show 25 more
Related Experiments (30)
Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m
validation · proposed · Score: 0.95
Single-cell RNA-seq analysis of mouse testes with gonadal de
exploratory · proposed · Score: 0.95
Sevoflurane-induced neurotoxicity (SIN) rat model
validation · proposed · Score: 0.95
FLS Stimulation and Transcriptomic Analysis
exploratory · proposed · Score: 0.95
Factor depletion effects on DDR focus formation in vivo
exploratory · proposed · Score: 0.90
scRNA-seq analysis of human atherosclerotic plaques
exploratory · proposed · Score: 0.90
Multi-omics analysis of NP137 mechanism in patient biopsies
exploratory · proposed · Score: 0.90
Sevoflurane-induced neurotoxicity (SIN) model in rats
validation · proposed · Score: 0.90
G3BP1-mediated stress granule assembly via liquid-liquid pha
exploratory · proposed · Score: 0.90
Single-cell RNA sequencing analysis of human atherosclerotic
exploratory · proposed · Score: 0.90
NPM1 knockout tumor progression study in syngeneic mice
validation · proposed · Score: 0.90
dilncRNA-mediated molecular crowding and phase separation
exploratory · proposed · Score: 0.90
Gestational haloperidol exposure effects on hippocampal gene
validation · proposed · Score: 0.90
Machine learning-based identification of C1Q hub genes
exploratory · proposed · Score: 0.90
Single-cell RNA sequencing of EMT states in SCC
exploratory · proposed · Score: 0.90
Single-cell RNA sequencing of mouse brains
exploratory · proposed · Score: 0.90
LINC00599 role in human PASMC proliferation
exploratory · proposed · Score: 0.90
LINC00599 expression analysis in hypoxic PH models
exploratory · proposed · Score: 0.90
DDR factor depletion and focus formation analysis
exploratory · proposed · Score: 0.90
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
Microarray and single-cell RNA analysis of lipid metabolism
exploratory · proposed · Score: 0.85
dilncRNA-mediated molecular crowding and phase separation
exploratory · proposed · Score: 0.85
LINC00599-MYH9 liquid-liquid phase separation analysis
exploratory · proposed · Score: 0.85
DSB-induced promoter assembly and RNA polymerase II recruitm
exploratory · proposed · Score: 0.85
Single-cell RNA sequencing of microglial states in AD hippoc
exploratory · proposed · Score: 0.85
Single-nucleus RNA-seq integration analysis
exploratory · proposed · Score: 0.85
Small RNA profiling of neonatal astrocyte EVs and microglia
exploratory · proposed · Score: 0.85
Netrin-1 and UNC5B knockdown effects on EMT in vitro
exploratory · proposed · Score: 0.85
Activity-dependent PGC-1α transcriptional program analysis
exploratory · proposed · Score: 0.80
PGC-1α expression analysis during PV+ interneuron developmen
exploratory · proposed · Score: 0.80
Show 25 more
See Also (15)
Yoga Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses
YAP/TEAD Pathway Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Wnt Signaling Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 139 hypotheses
Vitamin B Complex Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses
VIP/VPAC Receptor Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Urolithin A for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Urolithin A for Neurodegeneration
therapeutic · Pages share 139 hypotheses
tudca-udca-neurodegeneration
therapeutic · Pages share 139 hypotheses
TRPM8 Agonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Triple Incretin Agonists (GLP-1/GIP/Glucagon) for Neuro
therapeutic · Pages share 139 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Transcranial Magnetic Stimulation Therapy for Neurodege
therapeutic · Pages share 139 hypotheses
TLR7/8/9 Antagonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses
TLR4 Antagonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Show 10 more